Page last updated: 2024-12-08
1-phenylcyclopropylamine
Description
1-phenylcyclopropylamine is a **chemical compound** that combines a cyclopropyl ring (a three-membered ring of carbon atoms) with a phenyl ring (a six-membered ring of carbon atoms with alternating double bonds) and an amine group (NH2).
Here's why it's important in research:
**1. Biological Activity:**
* **Potent inhibitor of monoamine oxidase (MAO).** MAO is an enzyme that breaks down neurotransmitters like serotonin, dopamine, and norepinephrine. Inhibiting MAO can lead to increased levels of these neurotransmitters in the brain, making 1-phenylcyclopropylamine a potential therapeutic target for conditions like depression and Parkinson's disease.
* **Potential antidepressant activity.** Its MAO-inhibiting properties contribute to its potential as an antidepressant. Research is ongoing to explore its efficacy and safety in treating depression.
* **Potential anti-inflammatory activity.** Studies suggest that 1-phenylcyclopropylamine may exhibit anti-inflammatory properties, possibly by influencing the production of inflammatory mediators.
**2. Chemical and Synthetic Interest:**
* **Novel scaffold for drug discovery.** The unique structure of 1-phenylcyclopropylamine makes it an interesting scaffold for designing new drugs with specific therapeutic activities.
* **Stereochemical complexity.** The presence of a chiral center (asymmetric carbon) in the cyclopropyl ring allows for the existence of different stereoisomers of 1-phenylcyclopropylamine, each with potentially distinct biological activity.
**3. Studies on its Mechanism of Action:**
* Research focuses on understanding how 1-phenylcyclopropylamine interacts with MAO and other enzymes to elicit its biological effects.
* Investigating the specific molecular pathways involved in its potential antidepressant and anti-inflammatory properties.
**4. Potential Applications:**
* **Development of new antidepressants.**
* **Treatment of other neuropsychiatric disorders.**
* **Treatment of inflammatory conditions.**
It is important to note that research on 1-phenylcyclopropylamine is still ongoing, and its therapeutic potential is yet to be fully realized. Further studies are necessary to determine its safety and efficacy in humans.
1-phenylcyclopropylamine: RN refers to HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 194549 |
SCHEMBL ID | 57461 |
MeSH ID | M0131797 |
Synonyms (36)
Synonym |
1-phenyl-cyclopropylamine |
BB 0257510 |
AR-527/42979546 |
1-phenylcyclopropylamine |
AKOS000370007 |
1-phenylcyclopropan-1-amine |
41049-53-0 |
STK690278 |
1-phenylcyclopropanamine |
773012-60-5 |
A825413 |
1-phenyl-1-cyclopropanamine |
FT-0649007 |
AB22505 |
AB01334829-02 |
CS-B0487 |
SCHEMBL57461 |
1-phenyl cyclopropylamine |
1-phenyl -cyclopropylamine |
trans-phenylcyclopropylamine |
cyclopropanamine, 1-phenyl- |
TS-01725 |
AC-31165 |
mfcd05863520 |
1-amino-1-phenylcyclopropane |
DTXSID50276733 |
J-505089 |
cyclopropanamine,1-phenyl- |
SY002295 |
F9995-1832 |
CCG-358827 |
AMY15762 |
EN300-145933 |
SB37095 |
NCGC00342943-01 |
CS1233 |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |